- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske studier sponset av Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences
Totalt 828 resultater
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringKreft i spiserøret | Kjemoterapi | Immunterapi | Kjemoradioterapi | NimotuzumabKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringEndometriekarsinom | Tilbakevendende eller metastatisk | TP53 mutasjonKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Har ikke rekruttert ennåTrippel-negativ brystkreft i tidlig stadium med BRCA1/2-mutasjonerKina
-
Cancer Institute and Hospital, Chinese Academy...Har ikke rekruttert ennåLipider | Ung brystkreftpasient | Anti-tumor medikamentell terapi
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAdenokarsinom i bukspyttkjertelen | Avansert kreft | Narkotika bruk | Capecitabin | Oksaliplatin | Første linje | Kadonilimab | Nanoliposomalt irinotekanKina
-
Cancer Institute and Hospital, Chinese Academy...Har ikke rekruttert ennåBukspyttkjertelkreft
-
Cancer Institute and Hospital, Chinese Academy...Har ikke rekruttert ennå
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHepatocellulært karsinom | Strålebehandling | Tislelizumab | Tumor tromboseKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMetastatisk tykktarmskreftKina
-
Cancer Institute and Hospital, Chinese Academy...Har ikke rekruttert ennåIkke småcellet lungekreft | ERBB2 mutasjonsrelaterte svulster | Disitamab Vedotin | ERBB2 genduplisering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringPlateepitelkarsinom i hode og nakkeKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringPlateepitelkarsinom i hode og nakkeKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringLokalt tilbakevendende tykktarmskreftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMålrettet terapi | HR+/HER2- Avansert brystkreftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAvansert lungekarsinomKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringBrystkreft | Kjemoterapi effektKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringPasienter med avanserte solide svulsterKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSarkom, mykt vev | Stamme | Ekstremitet | Intensitetsmodulert strålebehandling | Store sårkomplikasjoner | Målrettet terapiKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Har ikke rekruttert ennå
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMetastatisk tykktarmskreftKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHormonreseptor positiv avansert brystkreftKina
-
Cancer Institute and Hospital, Chinese Academy...Har ikke rekruttert ennåRefraktær lymfom | DLBCL | MYD88 genmutasjon | Tilbakefall | CD79A genmutasjon | CD79B genmutasjon
-
Cancer Institute and Hospital, Chinese Academy...Har ikke rekruttert ennåHepatocellulært karsinom Resektabelt
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringEsophageal plateepitelkarsinomKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringKreft i spiserøret | Kjemoradiasjon | Kirurgi | Kjemoterapi effekt | Immunterapi | Målrettet terapi | Esophagogastric Juction CancerKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringLokalt avansert ikke-småcellet lungekreftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAvansert hepatocellulært karsinom | Strålebehandling | Sorafenib | ToripalimabKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringUbehandlede avanserte NSCLC-pasienter | FISK Identifisert ALK Fusion Positiv eller NegativKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringTrippel negativ brystkreftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringTrippel negativ brystkreftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHER2-positiv brystkreftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSamtidig kjemoradioterapi | Nasofaryngealt plateepitelkarsinom | Trinn II, III | Induksjonskjemoterapi | Reduser behandlingsintensitetenKina
-
Cancer Institute and Hospital, Chinese Academy...Har ikke rekruttert ennåHepatocellulært karsinomKina
-
Cancer Institute and Hospital, Chinese Academy...Har ikke rekruttert ennåLokalt avansert bukspyttkjertelkreftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringBrystneoplasmer | Gjentakelse av neoplasma, lokalKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Aktiv, ikke rekrutterendeStrålebehandling | Sintilimab | Samtidig kjemoradioterapi | Immunnæring | Lokalt avansert esophageal plateepitelkarsinomKina
-
Cancer Institute and Hospital, Chinese Academy...FullførtLokalt avansert endetarmskreft | FjernmetastaseKina
-
Cancer Institute and Hospital, Chinese Academy...FullførtKognitiv funksjon | Hjernemetastaser | Lungeneoplasma | Samtidig integrert boost | Hippocampus unngåelseKina